3SOF

Hello everybody,
Go, see and catch CBMX....

---> they have a contract with NVAX to find The vaccine....


CombiMatrix, Novavax To Team Up On Flu Vaccine Technology
9:59 AM EST November 9, 2005
NEWPORT BEACH, Calif. (Dow Jones)--Acacia Research Corp. (CBMX) unit CombiMatrix and Novavax Inc. (NVAX) are in collaboration to develop technology to speed up vaccine development that would enable rapid response to tackle threats of mutating strains such as those presented by the bird-flu virus.

"This has a huge market potential in the Asia Pacific region and we look forward to a long and fruitful relationship." ...Mr Steven Fang, Group CEO, CyGenics.

http://www.acnnewswire.net/article.asp?Art_ID=30903&lang=

...What do u think of it ?
It will run....

 ,



Dr. Jonathan W. Said Joins CombiMatrix Molecular Diagnostics' Scientific Advisory Board

"CombiMatrix Molecular Diagnostics is a true innovator in the development of molecular cancer diagnostics," stated Dr. Said. "I look forward to working with this team and am very excited about the future of CMD."

"We are very pleased that Jonathan is joining CMD's Scientific Advisory Board to provide critical knowledge in the area of lymphoma molecular pathology," said Matthew Watson, CEO of CombiMatrix Molecular Diagnostics. "We look forward to his insight and leadership as we begin to launch our diagnostic services."

Dr. Said is a prominent expert in the field of molecular diagnostics, with a particular focus on lymphoma. He is active in the United States, Canadian, and International Academy of Pathology, American Society for Hematopathology, American Society of Hematology, and College of American Pathologists. He is a well-known lecturer and has authored and co-authored articles in many peer-review journals including American Journal of Pathology, American Journal of Clinical Pathology, Cancer, Human Pathology, and New England Journal of Medicine.

Dr. Said received his medical degree from the University of Witwatersrand Medical School, Johannesburg, South Africa. He completed his residencies in pathology at the Mallory Institute of Pathology and Peter Bent Brigham Hospital, Boston, Massachusetts. He served a fellowship in Hematopathology at Peter Bent Brigham Hospital and fellowships in clinical and research pathology at Harvard Medical School -- http://www.healthcare.ucla.edu/institution/physician?personnel_id=9317


http://biz.yahoo.com/bw/051130/20051130005190.html?.v=1

make this stock going higher !!!!!!!!!!!

CBMX closed up 20 cents on the high of the day due to this news:

http://biz.yahoo.com/bw/051201/20051201005831.html?.v=1

Watch it tomorrow.

  ;)by: misc_info_04 <---------
Long-Term Sentiment: Strong Buy  12/01/05 10:16 pm
Msg: 21436 of 21459

Reuters: CBMX Risk Alert: LOW

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21240


Can anyone "detect" the Profit Trend?

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21099


this validates our microarray technolog

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21159


CBMX Arrays Accepted by FDA for QC Proj

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21178


past, present, and future (1)

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21142


past, present, and future (2)

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21143


http://cmdiagnostics.com/


Contract Research Services

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21168


vaccines designed to treat cancer (the future of medicine)

http://finance.messages.yahoo.com/bbs?.mm=FN&action=m&board=1602900656&tid=cbmx&; sid=1602900656&mid=21223

---->

 Yesterday's news...

CombiMatrix Enters into Distribution Agreement with Singapore-Based Cell Sciences; Cell Sciences to Distribute Arrays Including CombiMatrix's New Influenza Array

-->   http://www.pharmalive.com/News/index.cfm?articleid=295603&categoryid=15



-----------by: callmanagementthenprofit (45/the friendly skies)  12/01/05 05:36 pm-----------


That is very, very good advice.

Asia has an enormous contingent of trading firms who will start accumulating positions in CBMX all month long due to this development today.

Today's news is affirmation of Combimatrix's significant progress in the multi-national adoption of their platform technology which until now was at best relegated by most to mere educated speculation.

No hype intended but what lay ahead for Combimatrix will make NVAX and the other penny stock companies small potatoes by comparison.

While Combimatrix is not a H5N1-influenza play, per se, it is not a 1-trick pony, flavor-of-the-season trade either like most other stocks are that have attracted all the speculative money and momentum over the "buzz" surrounding Avian Flu.

What that fast trader money which bull raided the stock earlier did not understand and failed to consider, as some of us have read of those numerous posters who sold during and after the retracement and encouraged everyone else to do the same, was the ongoing developments and progress of Combimatrix's other multi-national developments addressing not just Avian Flu detection but all strains for influenza and Avian Flu mutation, including all types of cancers, viruses, and other insideous diseases.

Let us be reminded and repeat as nescessary that, unlike other Avian Flu plays, Combimatrix is a multi-faceted biotechnology company with a virtual monopoly on a platform that is already slated to become a new standard for wide scale disease detection and analysis for high efficacy, next generation therapies.

Some of the highest calibre names in medicine and science have recently either joined Combimatrix and signed on or voiced support for their science and platform.

The great thing now is that nearly everyone has left Combimatrix stock for other plays which were benefitting entirely from momentum caused by media "buzz" over influenza alone.

The point?! There is an armada of potential buyers which will rotate out of those other 1-trick pony plays to come into CBMX. We now know that the "potential" that Combimatrix possesses is enormous as confirmed by today's news and among other ongoing company developments.

                                                     

again...again'n'again !!!


CombiMatrix finds an Asian partner

CombiMatrix Corp. of Mukilteo has signed a distribution agreement with Cell Sciences of Singapore to distribute CombiMatrix's research products and services in six nations in Southeast Asia, including Indonesia and Hong Kong.

Some news......

Press Release   Source: Acacia Research Corporation

CombiMatrix Launches ElectraSense(TM) Influenza Surveillance System
Monday March 6, 7:00 am ET

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--March 6, 2006--Acacia Research Corporation (Nasdaq:CBMX - News; Nasdaq:ACTG - News) announced today that its CombiMatrix group has launched the ElectraSense(TM) Influenza Typing System based on CombiMatrix's propriety electrochemical detection technology and its Influenza A Typing Microarray.

Check it out today:



This stock has slipped under alot of people's radar.  Rarely is CBMX mentioned in discussion of bird flu stock plays.  However, CBMX is bird flu and so much more.  Do your DD on this company, you'll be impressed.

Applaud for the heads up guys
This is gonna be a good play i think...prices out from 3 magics

We're up ~10% pre-market. 

Then again, most bird flu stocks are gapping this morning.

Beautiful close today     More than double average volume and up AH

Update:

CBMX presenting today
http://www.washbio.org/displaycommon.cfm?an=1&subarticlenbr=13

Next week with NVAX in India
http://www.combimatrix.com/pr/030706.pdf

And next week with the Air Force
http://www.brooks.af.mil/AFRL/HEP/Biomarker_Biomonitor_Conference/program.html

Five times average volume today

Nasty drop at the same time GNBT did - but CBMX recovered and ended up closing up 7 cents.  It's not having a fun time AH on low volume, however - let's see what tomorrow brings.

The bird flu news today is not news.  Everyone already recognizes that the current strain will need to mutate before a human pandemic would occur.  It is still important to monitor any mutations, and CBMX has the tool to do just that.

Another stock I own took a hit too because of a poorly written headline:  INSM.
"Auditor Doubts Insmed Viability"  - another case of old news that has already been taken care of.

Who writes these headlines?

Anyway, here's today's update:

It was time to go upstairs !!!

...and that's not finished...(after GNBT....will come CBMX ! )